It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and obesity drug Wegovy, into the ...

Gilead Sciences' already dominant position in HIV pre-exposure prophylaxis (PrEP) could be extended if the FDA approves a new twice-yearly product later this year. The US regulator has started a ...

A U.S. bankruptcy judge on Wednesday granted initial approval of Saks Global’s bankruptcy financing, allowing the company to draw on $400 million in new ‌cash despite an objection from Saks' estranged ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

The Biocon-Biologics deal will unlock and create value for the bio-pharma company's shareholders, according to Kiran Mazumdar-Shaw, Chairperson and Managing Director of India's largest ...